ArticlesBioPharma August 9, 2024 Streamlining Bioprocesses with Automation Automation technologies used in the development and manufacture of biopharmaceuticals continue to evolve, provi Ross Burns
ArticlesUpstream August 8, 2024 Under pressure: exploring root causes of leaks in single-use mixers Single-use technology offers huge benefits for both flexibility and efficiency. It reduces downtime by eliminating Ross Burns
ArticlesRegulatory August 8, 2024 Address the complexity of protein characterization Since the FDA approved the first monoclonal based therapy in 1985, mAbs have had significant… Ross Burns
ArticlesDownstream August 8, 2024 Optimizing KiH bispecific antibody chromatography steps Bispecific antibodies (bsAbs) are a promising class of therapeutic agents due to their ability to… Ross Burns
ArticlesBioPharmaUpstream August 5, 2024 Sterilization Trends for Single-Use Consumables Single-use (SU) technologies increasingly find use today at all phases of the drug development cycle… Ross Burns
ArticlesDownstream July 25, 2024 Considerations in depth filter scale-up Depth filters are widely used in the biopharmaceutical industry. They are typically made of a… Ross Burns
ArticlesBioPharma July 25, 2024 Selected courses from cell culture and downstream process development to scale-up and manufacturing Develop your skills and those of your teams with training courses designed for researchers, process… Ross Burns
ArticlesBioPharma July 11, 2024 Reviewing the Importance of Biosimilarity and Interchangeability Developing a robust and reliable strategy for analytical studies of a biosimilar in development is… Ross Burns
ArticlesDownstreamDownstreamMultimedia July 11, 2024 Free handbook for column packing and maintenance Does large-scale column packing seem daunting? Impossible to get right? This new handbook can help!… Ross Burns
ArticlesDownstream July 11, 2024 Introducing the VH3 ligand ELISA kit Ensuring the safety and efficacy of antibody-based therapeutics is crucial in biotherapeutic manufacturing. Accurate testing… Ross Burns